Search Results - "SWAIDANI, Shadi"
-
1
TRAF Regulation of IL-17 Cytokine Signaling
Published in Frontiers in immunology (27-06-2019)“…Tumor necrosis factor receptor (TNFR)-associated factors or (TRAFs) are important mediators of Interleukin-17 (IL-17) cytokine signaling and contribute to…”
Get full text
Journal Article -
2
Direct and Differential Suppression of Myeloid-Derived Suppressor Cell Subsets by Sunitinib Is Compartmentally Constrained
Published in Cancer research (Chicago, Ill.) (01-05-2010)“…The antiangiogenic drug sunitinib is a receptor tyrosine kinase inhibitor with significant, yet not curative, therapeutic effects in metastatic renal cell…”
Get full text
Journal Article -
3
Epithelium: the interplay between innate and Th2 immunity
Published in Immunology and cell biology (01-03-2010)“…Mucosal epithelium functions not only as a physical barrier, but also as a regulator of innate and adaptive immune responses against foreign substances and…”
Get full text
Journal Article -
4
Act1, a U-box E3 ubiquitin ligase for IL-17 signaling
Published in Science signaling (13-10-2009)“…Interleukin-17 (IL-17), a proinflammatory cytokine mainly produced by cells of the T helper 17 (T(H)17) lineage, is required for host defense against bacterial…”
Get more information
Journal Article -
5
The Critical Role of Epithelial-Derived Act1 in IL-17- and IL-25-Mediated Pulmonary Inflammation
Published in The Journal of immunology (1950) (01-02-2009)“…IL-25 initiates, promotes, and augments Th2 immune responses. In this study, we report that Act1, a key component in IL-17-mediated signaling, is an essential…”
Get full text
Journal Article -
6
The Essential Role of Single Ig IL-1 Receptor-Related Molecule/Toll IL-1R8 in Regulation of Th2 Immune Response
Published in The Journal of immunology (1950) (01-03-2009)“…A novel cytokine IL-33, an IL-1 family member, signals via ST2 receptor and promotes Th2 responses, through the activation of NF-kappaB and MAP kinases…”
Get full text
Journal Article -
7
Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression
Published in Oncoimmunology (31-12-2023)“…The tumor microenvironment (TME) in ovarian cancer (OC) is characterized by immune suppression, due to an abundance of suppressive immune cells populations. To…”
Get full text
Journal Article -
8
TSG-6 Protein Is Crucial for the Development of Pulmonary Hyaluronan Deposition, Eosinophilia, and Airway Hyperresponsiveness in a Murine Model of Asthma
Published in The Journal of biological chemistry (04-01-2013)“…Hyaluronan (HA) deposition is often correlated with mucosal inflammatory responses, where HA mediates both protective and pathological responses. By modifying…”
Get full text
Journal Article -
9
Epithelial Cell-Specific Act1 Adaptor Mediates Interleukin-25-Dependent Helminth Expulsion through Expansion of Lin−c-Kit+ Innate Cell Population
Published in Immunity (Cambridge, Mass.) (25-05-2012)“…Interleukin-25 (IL-25 or IL-17E), a member of the structurally related IL-17 family, functions as an important mediator of T helper 2 cell-type (type 2)…”
Get full text
Journal Article -
10
Tumor Necrosis Factor-stimulated Gene-6 (TSG-6) Amplifies Hyaluronan Synthesis by Airway Smooth Muscle Cells
Published in The Journal of biological chemistry (04-01-2013)“…We tested the hypothesis that the artificial addition of heavy chains from inter-α-inhibitor to hyaluronan (HA), by adding recombinant TSG-6 (TNF-stimulated…”
Get full text
Journal Article -
11
Nitrotyrosine Proteome Survey in Asthma Identifies Oxidative Mechanism of Catalase Inactivation
Published in Journal of Immunology (01-05-2006)“…Reactive oxygen species and reactive nitrogen species produced by epithelial and inflammatory cells are key mediators of the chronic airway inflammation of…”
Get full text
Journal Article -
12
Myeloid-cell-specific role of Gasdermin D in promoting lung cancer progression in mice
Published in iScience (17-02-2023)“…The activities of the NLRP3 and AIM2 inflammasomes and Gasdermin D (GsdmD) are implicated in lung cancer pathophysiology but it’s not clear if their…”
Get full text
Journal Article -
13
Resveratrol As a Novel Treatment for Recurrent Epistaxis in SMAD4+ Hereditary Hemorrhagic Telangiectasia
Published in Blood (23-11-2021)“…Introduction Hereditary Hemorrhagic Telangiectasia (HHT) is an autosomal dominant disorder characterized by the development of arteriovenous malformations or…”
Get full text
Journal Article -
14
Epithelial-derived gasdermin D mediates nonlytic IL-1β release during experimental colitis
Published in The Journal of clinical investigation (03-08-2020)“…Gasdermin D (GSDMD) induces pyroptosis via the pore-forming activity of its N-terminal domain, cleaved by activated caspases associated with the release of…”
Get full text
Journal Article -
15
-
16
Tissue Factor (TF) Is Upregulated in Tumor-Bearing Mice Treated with Immune Checkpoint Inhibitor (ICI)
Published in Blood (15-11-2022)Get full text
Journal Article -
17
Immune Checkpoint Inhibitors (ICI) Promote Neutrophil-Platelet Aggregate and NET Formation in Tumor-Bearing Mice
Published in Blood (15-11-2022)Get full text
Journal Article -
18
Hyaluronan Rafts on Airway Epithelial Cells
Published in The Journal of biological chemistry (15-01-2016)“…Many cells, including murine airway epithelial cells, respond to a variety of inflammatory stimuli by synthesizing leukocyte-adhesive hyaluronan (HA) cables…”
Get full text
Journal Article -
19
Cytokine Profiling in Antiphospholipid Syndrome Demonstrates Persistent Immune Dysregulation and a Procoagulant Phenotype
Published in Blood (02-11-2023)“…Background: The antiphospholipid syndrome (APS) is an autoimmune thromboinflammatory disease characterized by thrombosis and the persistent detection of…”
Get full text
Journal Article -
20
Abundance of B Cell Receptors Harboring Elongated Polytyrosine and Polyserine Rich Motifs within Their Heavy Chain CDR3 Distinguishes Catastrophic and Antiphospholipid Syndrome
Published in Blood (23-11-2021)“…Antiphospholipid syndrome (APS) is defined by arterial and/or venous thrombosis and/or pregnancy morbidity along with persistent circulating antiphospholipid…”
Get full text
Journal Article